ATE341307T1 - Quaternäre verbindungen enthaltend propolis als wirkstoff - Google Patents

Quaternäre verbindungen enthaltend propolis als wirkstoff

Info

Publication number
ATE341307T1
ATE341307T1 AT03812165T AT03812165T ATE341307T1 AT E341307 T1 ATE341307 T1 AT E341307T1 AT 03812165 T AT03812165 T AT 03812165T AT 03812165 T AT03812165 T AT 03812165T AT E341307 T1 ATE341307 T1 AT E341307T1
Authority
AT
Austria
Prior art keywords
propolis
active ingredient
compounds containing
quaternary compounds
containing propolis
Prior art date
Application number
AT03812165T
Other languages
English (en)
Inventor
Mora Paolo Corvi
Fabio Carli
Tiziana Canal
Original Assignee
Actimex S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actimex S R L filed Critical Actimex S R L
Application granted granted Critical
Publication of ATE341307T1 publication Critical patent/ATE341307T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A61K8/988—Honey; Royal jelly, Propolis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03812165T 2002-12-02 2003-12-02 Quaternäre verbindungen enthaltend propolis als wirkstoff ATE341307T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002549A ITMI20022549A1 (it) 2002-12-02 2002-12-02 Composizione quaternaria comprendente come sostanza attiva la propolis.

Publications (1)

Publication Number Publication Date
ATE341307T1 true ATE341307T1 (de) 2006-10-15

Family

ID=32448917

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03812165T ATE341307T1 (de) 2002-12-02 2003-12-02 Quaternäre verbindungen enthaltend propolis als wirkstoff

Country Status (12)

Country Link
US (1) US7763282B2 (de)
EP (1) EP1572155B1 (de)
JP (1) JP2006511511A (de)
CN (1) CN100398090C (de)
AT (1) ATE341307T1 (de)
AU (1) AU2003296602A1 (de)
CA (1) CA2508034A1 (de)
DE (1) DE60308899T2 (de)
ES (1) ES2274318T3 (de)
IT (1) ITMI20022549A1 (de)
RU (1) RU2005120766A (de)
WO (1) WO2004050063A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4947758B2 (ja) * 2004-06-17 2012-06-06 森川健康堂株式会社 プロポリス抽出物の粉末状組成物及びその製造方法
JP2006025790A (ja) * 2004-06-17 2006-02-02 Morikawa Kenkoudou Kk プロポリスの水への可溶化方法
CN1311815C (zh) * 2005-05-08 2007-04-25 浙江大学 亚微米蜂胶微胶囊的制备方法
ITPD20050224A1 (it) * 2005-07-19 2007-01-20 Actimex Srl Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego
IT1395351B1 (it) 2009-07-09 2012-09-14 Axioma Srl Formulazioni orali ad elevata biodisponibilita' orale costituite da miscele di frazioni lipofile e idrofile ottenute a partire dalla propoli
JP4574742B1 (ja) * 2010-04-08 2010-11-04 有限会社ミールジャパン プロポリス組成物
JP5725832B2 (ja) * 2010-12-16 2015-05-27 株式会社クラレ 化学的機械的研磨法およびそれに用いられるスラリー
WO2012092673A1 (en) 2011-01-08 2012-07-12 Kane Penny Colleen Bee bloom compositions, methods of extraction and uses thereof
WO2016010440A1 (en) * 2014-07-18 2016-01-21 Manuka Health New Zealand Limited Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health
GR1009068B (el) * 2016-05-09 2017-07-05 Πετρος Παναγιωτη Παναγιωτου Θεραπευτικο σκευασμα για πληγες κατακλισεων που, ψεκαζομενο επανω στην πληγη, δημιουργει επουλωτικη κρουστα - επιδεσμο

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876816A (en) * 1972-10-25 1975-04-08 Dynapol Corp Nonabsorbable, nonnutritive sweeteners
DE3279437D1 (en) * 1982-12-01 1989-03-16 Zenon M Sosnowski Method for extracting propolis and water soluble dry propolis powder obtained thereby and cosmetic and pharmaceutical preparations containing same
JPS60188036A (ja) * 1984-03-08 1985-09-25 Riken Vitamin Co Ltd グリチルリチン酸またはその塩類の呈味改善法
US6005100A (en) * 1992-12-02 1999-12-21 Kabushiki Kaisha Hayashibara Seitbutsu Kagaku Kenkyujo Trehalose composition for prolonging product shelf life
CN1081831A (zh) * 1993-05-20 1994-02-16 李前远 一种保健口香糖及其制备方法
US5922324A (en) * 1995-01-31 1999-07-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Propolis extract with improved water-solubility
JPH09206003A (ja) * 1996-02-06 1997-08-12 San Herusen Kk プロポリスパウダーの製造方法
JPH1025255A (ja) * 1996-07-11 1998-01-27 Taisho Pharmaceut Co Ltd 溶解性の改善された難溶性薬剤
JP2784349B2 (ja) * 1996-08-26 1998-08-06 アピ株式会社 食品用プロポリス組成物及びその製造方法
US20030104018A1 (en) * 1996-12-31 2003-06-05 Griscom Bettle Skin product having micro-spheres, and processes for the production thereof
NZ337592A (en) * 1997-03-13 2001-01-26 Hexal Ag Stabilization of acid sensitive benzimidazoles with amino/cyclodextrin combinations
IT1304190B1 (it) * 1998-12-18 2001-03-08 Euphar Group Srl Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche
JP2000316498A (ja) * 1999-04-30 2000-11-21 Piizu Communications:Kk 水抽出プロポリスエキス及びその製造方法
JP2001010963A (ja) * 1999-06-29 2001-01-16 Api Co Ltd プロポリス粉末組成物及びその製造方法
ITMI20021074A1 (it) * 2002-05-20 2003-11-20 Actimex S R L Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione

Also Published As

Publication number Publication date
ITMI20022549A1 (it) 2004-06-03
EP1572155B1 (de) 2006-10-04
CN100398090C (zh) 2008-07-02
DE60308899T2 (de) 2007-05-10
CA2508034A1 (en) 2004-06-17
RU2005120766A (ru) 2006-02-10
AU2003296602A1 (en) 2004-06-23
ES2274318T3 (es) 2007-05-16
DE60308899D1 (de) 2006-11-16
JP2006511511A (ja) 2006-04-06
WO2004050063A1 (en) 2004-06-17
EP1572155A1 (de) 2005-09-14
CN1720023A (zh) 2006-01-11
US20060013891A1 (en) 2006-01-19
US7763282B2 (en) 2010-07-27

Similar Documents

Publication Publication Date Title
EA200301275A1 (ru) Капсулы для ингаляции
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
YU73503A (sh) Preparati insulina koji ne sadrže cink ili sadrže male količine cinka i koji imaju poboljšanu stabilnost
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
SG127738A1 (en) Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds
HK1064295A1 (en) Medical aerosol formulations
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
MY147373A (en) Piperazine derivatives as antimalarial agents
DE60207894D1 (en) 4-(piperidyl- und pyrrolidyl-alkyl-ureido)-chinoline als urotensin ii rezeptor antagonisten
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2004026836A8 (en) 1-pyridin-4-yl-urea derivatives
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
ATE341307T1 (de) Quaternäre verbindungen enthaltend propolis als wirkstoff
HUP0102515A2 (hu) Ciklopeptidek, eljárás előállításukra, hatóanyagként azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
WO2005065639A3 (en) Novel pharmaceutical compositions
IL179865A0 (en) Pharmaceutical composition comprising 5 - [[4-[3 - methyl- 4- oxo - 3,4 - dihydro - 2 - quinazolinyl]methoxy] phenyl-methyl]thiadiazolidine-2,4- dione in the form of a tablet a powder or a capsule and the process for its preparation
AU2001289714A1 (en) Benzofuran derivatives and their use as antibacterial agents
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
EA200500671A1 (ru) Фармацевтический состав оланзапина
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1572155

Country of ref document: EP

REN Ceased due to non-payment of the annual fee